Publications en collaboration avec des chercheurs de Hospital de la Santa Creu i Sant Pau (5)

2024

  1. Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study

    Diabetes and Metabolism, Vol. 50, Núm. 1

2022

  1. Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 82-90

  2. Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care—APHOSDIAB—COVID-19 Multicenter Study

    Journal of Clinical Medicine, Vol. 11, Núm. 8

2018

  1. A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain

    Diabetes Research and Clinical Practice, Vol. 137, pp. 56-63

  2. Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results

    Diabetes Technology and Therapeutics, Vol. 20, Núm. 5, pp. 380-385